 | • レポートコード：GIR-23F3944 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Tasigna Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のタシグナの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 タシグナ市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・50mg、200mg、その他 アプリケーション別セグメントは次のように区分されます。 ・病院、ドラッグストア、その他 世界のタシグナ市場の主要なマーケットプレーヤーは以下のとおりです。 ・Novartis 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - タシグナの概要 - タイプ別分析（2017年vs2021年vs2028年）：50mg、200mg、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、ドラッグストア、その他 - 世界のタシグナ市場規模・予測 - 世界のタシグナ生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Novartis ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：50mg、200mg、その他 ・アプリケーション別分析2017年-2028年：病院、ドラッグストア、その他 ・タシグナの北米市場分析 - タシグナの北米市場：タイプ別市場規模2017年-2028年 - タシグナの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・タシグナのヨーロッパ市場分析 - ：タシグナのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：タシグナのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・タシグナのアジア太平洋市場分析 - タシグナのアジア太平洋市場：タイプ別市場規模2017年-2028年 - タシグナのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・タシグナの南米市場分析 - タシグナの南米市場：タイプ別市場規模2017年-2028年 - タシグナの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・タシグナの中東・アフリカ市場分析 - タシグナの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - タシグナの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Tasigna market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tasigna market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Tasigna global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 50mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tasigna include Novartis, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tasigna market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
50mg
200mg
Other
Market segment by Application can be divided into
Hospital
Drugs Store
Other
The key market players for global Tasigna market are listed below:
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tasigna product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tasigna, with price, sales, revenue and global market share of Tasigna from 2019 to 2022.
Chapter 3, the Tasigna competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tasigna breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tasigna market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tasigna.
Chapter 13, 14, and 15, to describe Tasigna sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Tasigna Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tasigna Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 50mg
1.2.3 200mg
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Tasigna Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Tasigna Market Size & Forecast
1.4.1 Global Tasigna Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tasigna Sales in Volume (2017-2028)
1.4.3 Global Tasigna Price (2017-2028)
1.5 Global Tasigna Production Capacity Analysis
1.5.1 Global Tasigna Total Production Capacity (2017-2028)
1.5.2 Global Tasigna Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tasigna Market Drivers
1.6.2 Tasigna Market Restraints
1.6.3 Tasigna Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Tasigna Product and Services
2.1.4 Novartis Tasigna Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tasigna Breakdown Data by Manufacturer
3.1 Global Tasigna Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tasigna Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tasigna
3.4 Market Concentration Rate
3.4.1 Top 3 Tasigna Manufacturer Market Share in 2021
3.4.2 Top 6 Tasigna Manufacturer Market Share in 2021
3.5 Global Tasigna Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tasigna Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tasigna Market Size by Region
4.1.1 Global Tasigna Sales in Volume by Region (2017-2028)
4.1.2 Global Tasigna Revenue by Region (2017-2028)
4.2 North America Tasigna Revenue (2017-2028)
4.3 Europe Tasigna Revenue (2017-2028)
4.4 Asia-Pacific Tasigna Revenue (2017-2028)
4.5 South America Tasigna Revenue (2017-2028)
4.6 Middle East and Africa Tasigna Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tasigna Sales in Volume by Type (2017-2028)
5.2 Global Tasigna Revenue by Type (2017-2028)
5.3 Global Tasigna Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tasigna Sales in Volume by Application (2017-2028)
6.2 Global Tasigna Revenue by Application (2017-2028)
6.3 Global Tasigna Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tasigna Sales by Type (2017-2028)
7.2 North America Tasigna Sales by Application (2017-2028)
7.3 North America Tasigna Market Size by Country
7.3.1 North America Tasigna Sales in Volume by Country (2017-2028)
7.3.2 North America Tasigna Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tasigna Sales by Type (2017-2028)
8.2 Europe Tasigna Sales by Application (2017-2028)
8.3 Europe Tasigna Market Size by Country
8.3.1 Europe Tasigna Sales in Volume by Country (2017-2028)
8.3.2 Europe Tasigna Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tasigna Sales by Type (2017-2028)
9.2 Asia-Pacific Tasigna Sales by Application (2017-2028)
9.3 Asia-Pacific Tasigna Market Size by Region
9.3.1 Asia-Pacific Tasigna Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tasigna Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tasigna Sales by Type (2017-2028)
10.2 South America Tasigna Sales by Application (2017-2028)
10.3 South America Tasigna Market Size by Country
10.3.1 South America Tasigna Sales in Volume by Country (2017-2028)
10.3.2 South America Tasigna Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tasigna Sales by Type (2017-2028)
11.2 Middle East & Africa Tasigna Sales by Application (2017-2028)
11.3 Middle East & Africa Tasigna Market Size by Country
11.3.1 Middle East & Africa Tasigna Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tasigna Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tasigna and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tasigna
12.3 Tasigna Production Process
12.4 Tasigna Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tasigna Typical Distributors
13.3 Tasigna Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Tasigna Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Tasigna Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Tasigna Product and Services
Table 6. Novartis Tasigna Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Tasigna Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 8. Global Tasigna Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Tasigna, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Tasigna Production Capacity by Company, (MT): 2020 VS 2021
Table 11. Head Office and Tasigna Production Site of Key Manufacturer
Table 12. Tasigna New Entrant and Capacity Expansion Plans
Table 13. Tasigna Mergers & Acquisitions in the Past Five Years
Table 14. Global Tasigna Sales by Region (2017-2022) & (MT)
Table 15. Global Tasigna Sales by Region (2023-2028) & (MT)
Table 16. Global Tasigna Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Tasigna Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Tasigna Sales by Type (2017-2022) & (MT)
Table 19. Global Tasigna Sales by Type (2023-2028) & (MT)
Table 20. Global Tasigna Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Tasigna Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Tasigna Price by Type (2017-2022) & (USD/Kg)
Table 23. Global Tasigna Price by Type (2023-2028) & (USD/Kg)
Table 24. Global Tasigna Sales by Application (2017-2022) & (MT)
Table 25. Global Tasigna Sales by Application (2023-2028) & (MT)
Table 26. Global Tasigna Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Tasigna Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Tasigna Price by Application (2017-2022) & (USD/Kg)
Table 29. Global Tasigna Price by Application (2023-2028) & (USD/Kg)
Table 30. North America Tasigna Sales by Country (2017-2022) & (MT)
Table 31. North America Tasigna Sales by Country (2023-2028) & (MT)
Table 32. North America Tasigna Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Tasigna Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Tasigna Sales by Type (2017-2022) & (MT)
Table 35. North America Tasigna Sales by Type (2023-2028) & (MT)
Table 36. North America Tasigna Sales by Application (2017-2022) & (MT)
Table 37. North America Tasigna Sales by Application (2023-2028) & (MT)
Table 38. Europe Tasigna Sales by Country (2017-2022) & (MT)
Table 39. Europe Tasigna Sales by Country (2023-2028) & (MT)
Table 40. Europe Tasigna Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Tasigna Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Tasigna Sales by Type (2017-2022) & (MT)
Table 43. Europe Tasigna Sales by Type (2023-2028) & (MT)
Table 44. Europe Tasigna Sales by Application (2017-2022) & (MT)
Table 45. Europe Tasigna Sales by Application (2023-2028) & (MT)
Table 46. Asia-Pacific Tasigna Sales by Region (2017-2022) & (MT)
Table 47. Asia-Pacific Tasigna Sales by Region (2023-2028) & (MT)
Table 48. Asia-Pacific Tasigna Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Tasigna Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Tasigna Sales by Type (2017-2022) & (MT)
Table 51. Asia-Pacific Tasigna Sales by Type (2023-2028) & (MT)
Table 52. Asia-Pacific Tasigna Sales by Application (2017-2022) & (MT)
Table 53. Asia-Pacific Tasigna Sales by Application (2023-2028) & (MT)
Table 54. South America Tasigna Sales by Country (2017-2022) & (MT)
Table 55. South America Tasigna Sales by Country (2023-2028) & (MT)
Table 56. South America Tasigna Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Tasigna Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Tasigna Sales by Type (2017-2022) & (MT)
Table 59. South America Tasigna Sales by Type (2023-2028) & (MT)
Table 60. South America Tasigna Sales by Application (2017-2022) & (MT)
Table 61. South America Tasigna Sales by Application (2023-2028) & (MT)
Table 62. Middle East & Africa Tasigna Sales by Region (2017-2022) & (MT)
Table 63. Middle East & Africa Tasigna Sales by Region (2023-2028) & (MT)
Table 64. Middle East & Africa Tasigna Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Tasigna Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Tasigna Sales by Type (2017-2022) & (MT)
Table 67. Middle East & Africa Tasigna Sales by Type (2023-2028) & (MT)
Table 68. Middle East & Africa Tasigna Sales by Application (2017-2022) & (MT)
Table 69. Middle East & Africa Tasigna Sales by Application (2023-2028) & (MT)
Table 70. Tasigna Raw Material
Table 71. Key Manufacturers of Tasigna Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Tasigna Typical Distributors
Table 75. Tasigna Typical Customers
List of Figures
Figure 1. Tasigna Picture
Figure 2. Global Tasigna Revenue Market Share by Type in 2021
Figure 3. 50mg
Figure 4. 200mg
Figure 5. Other
Figure 6. Global Tasigna Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Drugs Store
Figure 9. Other
Figure 10. Global Tasigna Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 11. Global Tasigna Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Tasigna Sales (2017-2028) & (MT)
Figure 13. Global Tasigna Price (2017-2028) & (USD/Kg)
Figure 14. Global Tasigna Production Capacity (2017-2028) & (MT)
Figure 15. Global Tasigna Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Tasigna Market Drivers
Figure 17. Tasigna Market Restraints
Figure 18. Tasigna Market Trends
Figure 19. Global Tasigna Sales Market Share by Manufacturer in 2021
Figure 20. Global Tasigna Revenue Market Share by Manufacturer in 2021
Figure 21. Tasigna Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Tasigna Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Tasigna Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Tasigna Sales Market Share by Region (2017-2028)
Figure 25. Global Tasigna Revenue Market Share by Region (2017-2028)
Figure 26. North America Tasigna Revenue (2017-2028) & (USD Million)
Figure 27. Europe Tasigna Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Tasigna Revenue (2017-2028) & (USD Million)
Figure 29. South America Tasigna Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Tasigna Revenue (2017-2028) & (USD Million)
Figure 31. Global Tasigna Sales Market Share by Type (2017-2028)
Figure 32. Global Tasigna Revenue Market Share by Type (2017-2028)
Figure 33. Global Tasigna Price by Type (2017-2028) & (USD/Kg)
Figure 34. Global Tasigna Sales Market Share by Application (2017-2028)
Figure 35. Global Tasigna Revenue Market Share by Application (2017-2028)
Figure 36. Global Tasigna Price by Application (2017-2028) & (USD/Kg)
Figure 37. North America Tasigna Sales Market Share by Type (2017-2028)
Figure 38. North America Tasigna Sales Market Share by Application (2017-2028)
Figure 39. North America Tasigna Sales Market Share by Country (2017-2028)
Figure 40. North America Tasigna Revenue Market Share by Country (2017-2028)
Figure 41. United States Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Tasigna Sales Market Share by Type (2017-2028)
Figure 45. Europe Tasigna Sales Market Share by Application (2017-2028)
Figure 46. Europe Tasigna Sales Market Share by Country (2017-2028)
Figure 47. Europe Tasigna Revenue Market Share by Country (2017-2028)
Figure 48. Germany Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Tasigna Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Tasigna Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Tasigna Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Tasigna Revenue Market Share by Region (2017-2028)
Figure 57. China Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Tasigna Sales Market Share by Type (2017-2028)
Figure 64. South America Tasigna Sales Market Share by Application (2017-2028)
Figure 65. South America Tasigna Sales Market Share by Country (2017-2028)
Figure 66. South America Tasigna Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Tasigna Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Tasigna Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Tasigna Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Tasigna Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Tasigna Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Tasigna in 2021
Figure 78. Manufacturing Process Analysis of Tasigna
Figure 79. Tasigna Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
| 【タシグナについて】 タシグナ（Tasigna）とは、主に慢性骨髄性白血病（CML）やギマザクリブ（Gleevec）耐性の急性リンパ性白血病（ALL）治療に用いられる抗がん剤です。一般名はニロチニブ（nilotinib）であり、チロシンキナーゼ阻害薬の一種です。タシグナは、特にフィラデルフィア染色体の異常を持つがん細胞に対して効果を発揮します。ここでは、タシグナの定義、特徴、種類、用途、関連技術について詳しく解説します。 タシグナの定義としては、慢性骨髄性白血病などの特定のがんに対する治療薬であり、分子標的治療の一環として位置づけられます。従来の化学療法に比べて、正常細胞への影響を軽減しつつ、がん細胞に対して選択的に作用することが特徴です。タシグナは、がん細胞の増殖に必要な酵素であるチロシンキナーゼを阻害することで、がんの進行を抑制します。 タシグナの特徴は、特に作用の選択性にあります。細胞内の特定のシグナル伝達経路に影響を与えることによって、がん細胞の生存や増殖を抑え、患者の生活の質を向上させる役割を果たします。ニロチニブは、BCR-ABL融合遺伝子が生成するチロシンキナーゼを強力に阻害するため、フィラデルフィア染色体陽性のがんに対して特に効果的です。また、タシグナは経口投与が可能であり、投与が簡便である点も大きな利点とされています。 タシグナの種類としては、基本的にチロシンキナーゼ阻害薬のカテゴリーに分類される薬剤に含まれます。主な同類薬には、イマチニブ（Gleevec）やダサチニブ（Sprycel）などがあります。それぞれの薬剤には特徴があり、患者の状態や耐性の有無に応じて使い分けが行われます。タシグナは、特にイマチニブに対する耐性を示した患者に対する治療選択肢の一つとして利用されることが多いです。 タシグナの主な用途は、CMLとALLの治療にあります。CMLは、脊椎の骨髄において通常の血液細胞の生成が妨げられ、異常な細胞が増加する病気です。CMLの進行に伴い患者はさまざまな症状を経験し、末期には生命を脅かす可能性もあります。タシグナは、この病気に対する効果的な治療法として、臨床試験でもその有効性が確認されています。 また、タシグナは副作用として、皮膚の発疹、肝機能障害、血液検査での異常、QT延長症候群などが認められることがあります。これらの副作用は、タシグナが体内でどのように代謝され、どのような経路を通るかに問いかけられています。投与する際には、医師が適切な用量を設定し、副作用をモニターすることが重要です。タシグナは、個々の患者の体調や病状に応じて調整が必要な場合が多いです。 関連技術としては、分子標的治療の進歩や、個別化医療の概念が挙げられます。最近の医療研究では、患者の遺伝子、がんの特性を考慮した治療法が注目されています。タシグナもその一例であり、正常細胞をできるだけ傷つけずにがん細胞を攻撃するための新たなアプローチの象徴とも捉えられています。これにより、従来の治療法では難しいとされていた病状へのアプローチが可能となり、多くの患者に希望を与えています。 結論として、タシグナは慢性骨髄性白血病や急性リンパ性白血病の治療において重要な役割を果たす抗がん剤です。効能、副作用、関連技術についての理解を深めることで、患者にとって最適な治療法を選ぶ手助けとなります。医療の進歩とともに、さらに多くの患者がこの治療の恩恵を受けられることが期待されます。 |